🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stage IV Ovarian Cancer

Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy NCT07144826EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial NCT07158021Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Biospecimen Collection, Electronic Health Record Review, Goserelin, Leuprolide, Questionnaire Administration A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites📍 Ryde📍 Sydney📍 Westmead EtiraRx Australia Pty Ltd · Tests: ERX-315 Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study NCT07311577Phase 22 sites📍 Nanjing📍 Nanjing Jiangsu Cancer Institute & Hospital · Tests: RC48+Carboplatin+Bevacizumab The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer NCT07636200NA2 sites📍 Aurora📍 Boulder University of Colorado, Boulder · Tests: Written Exposure-Based Coping Intervention (EASE), Usual Care Control Condition Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer NCT07718854Phase 21 site📍 Boston Tufts Medical Center · Tests: Sacituzumab tirumotecan, Pembrolizumab Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT07665515Phase 110 sites📍 Cambridge📍 Edinburgh📍 Glasgow Epitopea Ltd · Tests: CryptiVax-1001 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites📍 Birmingham📍 Anchorage📍 Anchorage NRG Oncology · Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression NCT06839144Phase 22 sites📍 Ramat Gan📍 Tel Aviv Tel-Aviv Sourasky Medical Center · Tests: Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor), Placebo (Matching for Propranolol & Etodolac) Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites📍 Miami📍 Weston📍 Boston M.D. Anderson Cancer Center · Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy NCT03275194Phase 21 site📍 Mexico City Instituto Nacional de Cancerologia de Mexico · Tests: HIPEC Measuring Oncological Value of Exercise and Statin NCT05796973Phase 31 site📍 Tampere Tampere University Hospital · Tests: Guided physical exercise, Atorvastatin, Independent exercise Prehabilitation in Gynaecological Cancer Patients NCT04789694Phase 31 site📍 Prague Charles University, Czech Republic · Tests: Physiological intervention, Psychological intervention, Nutritional intervention PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer NCT07472140Phase 2, Phase 31 site📍 Minsk N.N. Alexandrov National Cancer Centre · Tests: PARP inhibitor + Bevacizumab, PARP inhibitor CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors NCT05410717Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer NCT04701645Phase 12 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Microdevice Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer NCT01000259n/a1 site📍 Philadelphia Gynecologic Oncology Group · Tests: Laboratory Biomarker Analysis Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer NCT05737303Phase 311 sites📍 Guangzhou📍 Ji'nan📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: nab-paclitaxel combined with carboplatin Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer NCT04794322n/a6 sites📍 Little Rock📍 San Francisco📍 Annapolis Massachusetts General Hospital · Tests: Uterine lavage, or a wash of the womb, Blood sample, Pap smear Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy NCT07340164Phase 21 site📍 Seoul Yonsei University · Tests: Trastzumab Deruxtecan, Bevacizumab, Platinum Based Chemotherapy Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites📍 Birmingham📍 Mobile📍 Anchorage National Cancer Institute (NCI) · Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine NCT06682988Phase 252 sites📍 Sarasota📍 Edgewood📍 Lexington AbbVie · Tests: Mirvetuximab Soravtansine IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors NCT07715747Phase 11 site📍 Shanghai TJ Biopharma Co., Ltd. · Tests: TJ037130 HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer NCT06014190Phase 228 sites📍 Hefei📍 Beijing📍 Beijing Hansoh BioMedical R&D Company · Tests: HS-20089 Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors NCT03067181Phase 3629 sites📍 Birmingham📍 Mobile📍 Anchorage Children's Oncology Group · Tests: Best Practice, Biopsy Procedure, Biospecimen Collection, Bleomycin Sulfate, Carboplatin Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy NCT04997096NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Exercise, Attention Control Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery NCT06290193Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Acute Normovolemic Hemodilution/ANH
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy